Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Antiviral Research|March 28, 2018
Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic mannersLeiqi Xu, Zhuanchang Wu, Siyu Tan, et al.
Cell Proliferation|August 19, 2020
Acute stress disrupts intestinal homeostasis via GDNF-RETLin Lin, Bingcheng Feng, Ruchen Zhou, et al.
Scientific Reports|October 31, 2025
An automatic severity grading system using confocal laser endomicroscopy to evaluate inflammatory activity of ulcerative colitis: a prospective studyPeiting Xue, Jing Guo, Zhilong Che, et al.
Nutrients|August 12, 2023
Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis-A Multicenter Cross-Sectional Survey in ChinaYang Chen, Xiaohong Sun, Wenjuan Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 12, 2026
Transferable Deep Reinforcement Learning With Edge-Contour-Depth Fusion for Autonomous Wireless Capsule Endoscopy NavigationHaoxuan Wu, Haitao Gao, Qingyang Liu, et al.
JAMA Network Open|January 30, 2025
Automatic Quality Control System and Adenoma Detection Rates During Routine Colonoscopy: A Randomized Clinical TrialJing Liu, Ruchen Zhou, Chengxia Liu, et al.
BMC Medicine|May 2, 2026
Impact of a real-time automatic quality control system for magnetically controlled capsule gastroscopy: a multicenter randomized controlled trialXiaoya Wang, Dawei Shen, Yusha Zhao, et al.
Helicobacter|April 16, 2025
Efficacy and Safety of Cefuroxime-Tetracycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Penicillin-Allergic Patients: A Multicenter Randomized Controlled TrialHui Wang, Qingzhou Kong, Qiumei Zhang, et al.
Helicobacter|June 14, 2024
Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled TrialZhongxue Han, Qiumei Zhang, Iqtida Ahmed Mirza, et al.
The Journal of Infectious Diseases|January 30, 2026
Comparative Analysis of High-Dose Dual Therapies in First-Line Helicobacter pylori Eradication: An Inverse Probability of Treatment-Weighted Multicenter StudyQingzhou Kong, Baobao Wang, Bengang Zhou, et al.
Pageof 11